Effects of acute and repeated oral doses of D-tagatose on plasma uric acid in normal and diabetic humans

Regulatory Toxicology and Pharmacology

Volumn 29, Issue 2 I, 1999, Pages

  Saunders, James P ^a   Donner, Thomas W ^b   Sadler, John H ^c   Levin, Gilbert V ^a   Makris, Nicolaus G ^d  

^a Biospherics Incorporated   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d NMC   (United States)

Author keywords

D tagatose; Humans; Uric acid

Indexed keywords

TAGATOSE; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG ABSORPTION; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLATULENCE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUCROSE; GLUCOSE TOLERANCE TEST; HEXOSES; HUMANS; SWEETENING AGENTS; TIME FACTORS; URIC ACID;

EID: 0033021050     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1998.1264     Document Type: Article

References (33)

1. Beadle, J. R., Saunders, J. P., and Wajda, T. J. (1991). U.S. Patent 5,002,612.
2. Beadle, J. R., Saunders, J. P., and Wajda, T. J. (1992). U.S. Patent 5,078,796.
3. Brady, H. R., Brenner, B. M., and Lieberthal, W. (1996). Acute renal failure. In Brenner and Rector's: The Kidney (B. M. Brenner, Ed.), 5th ed., p. 1207, Saunders, Philadelphia, PA.
4. Buemann, B., Toubro, S., and Astrup, A. (1998a). D-Tagatose, a stereoisomer of D-fructose, increases hydrogen production in humans without affecting 24-hour energy expenditure, or respiratory exchange ratio. J. Nutr. 128, 1481-1486.
5. Buemann, B., Toubro, S., Holst, J. J., Rehfeld, J., and Astrup, A. (1998b). D-Tagatose, a stereoisomer of D-fructose, increases blood uric acid concentration. Submitted for publication.
6. Davidson, M. B. (1995). Clinical implications of insulin resistance syndromes. Am. J. Med. 99, 420-426.
7. Davies, P. M., Simmonds, H. A., Singer, B., Mant, T. G., Allen, E. M., Vassos, A. B., and Hounslow, N. J. (1998). Plasma uridine as well as uric acid is elevated following fructose loading. Adv. Exp. Med. Biol. 431, 31-35.
8. Fessel, W. J. (1979). Renal outcomes of gout and hyperuricemia. Am. J. Med. 67, 74-82.
9. Förster, H., Boecker, S., and Ziege, M. (1972). Anstieg der konzentration der serumharnsäure nach akuter und chronischer zufuhr von saccharose, fructose, Sorbit und Xylit. Medizin und Ernährung 13, 193-196.
10. Förster, H., and Hoos, I. (1977). Carbohydrate induced increase in uric acid synthesis. Studies in human volunteers and in laboratory rats. Adv. Exp. Med. Biol. 7617, 519-528.
11. Förster, H., and Ziege, M. (1971). Anstieg der Serumharnsäurekonzentration nach oraler Zufuhr von Fructose, Sorbit und Xylit. Zeitschrift für Ernährungswissenschaft 10, 394-396.
12. Hall, A. P., Barry, P. E., Dawber, T. R., and McNamara, P. M. (1967). Epidemiology of gout and hyperuricemia: A long-term population study. Am. J. Med. 42, 27-37.
13. Hallfrisch, J. (1990). Metabolic effects of dietary fructose FASEB J. 4, 2652-2660.
14. Johansen, H. N., and Jensen, B. B. (1997). Recovery of energy as SCFA after microbial fermentation of D-tagatose. Int. J. Obes. 21(Suppl. 2), S50. [Abstract]
15. Kogut, M. D., Roe, T. F., Won, N. G., and Donnell, G. N. (1975). Fructose-induced hyperuricemia: observations in normal children and in patients with hereditary fructose intolerance and galactosemia. Pediat. Res. 9, 774-778.
16. Levin, G. V., Zehner, L. R., Saunders, J. P., and Beadle, J. R. (1995). Sugar substitutes: their energy values, bulk characteristics, and potential health benefits. Am. J. Clin. Nutr. 62(Suppl.), 1161S-1168S.
17. Livesey, G., and Brown, J. C. (1996). D-Tagatose is a bulk sweetener with zero energy determined in rats. J. Nutr. 126, 1601-1609.
18. Macdonald, I., Keyser, A., and Pacy, D. (1978). Some effects, in man, of varying the load of glucose, sucrose, fructose, or sorbitol on various metabolites in blood. Am. J. Clin. Nutr. 31, 1305-1311.
19. Martinez, P., Carrascosa, J. M., and Nunez de Castro, I. (1987). Ketose induced respiratory inhibition in isolated hepatocytes. Rev. Esp. Fisiol. 43(2), 163-172.
20. 31P-magnetic resonance spectroscopy in man and rats. Biochim. Biophys. Acta 1199, 166-174.
21. Mayes, P. A. (1993). Intermediary metabolism of fructose. Am J. Clin. Nutr. 58 (suppl), 754S-765S.
22. Milliken, G. A., and Johnson, D. E. (1984). In Analysis of Messy Data: Designed Experiments, Vol. 1, pp. 78-80, Van Nostrand Reinhold, New York.
23. Narins, R. G., Weisberg, J. S., and Myers, A. R. (1974). Effects of carbohydrates on uric acid metabolism. Metabolism 23, 455-465.
24. Neter, J., and Wasserman, W. (1977). In Applied Linear Statistical Models, 7th printing, pp. 745-747, Richard D. Irwin, Inc., Homewood, IL.
25. 31P magnetic resonance spectroscopy. Lancet 931-934.
26. Raushel, F. M., and Cleland, W. W. (1973). The substrate and anomeric specificity of fructokinase. J. Biol. Chem. 248(23), 8174-8177.
27. Reiser, S., Scholfield, D., Trout, D., Wilson, A., and Aparicio, P. (1984). Effect of glucose and fructose on the absorption of leucine in humans. Nutr. Rep. Int. 30, 151-162.
28. Snedecor, G. W., and Cochran, W. G. (1974). In Statistical methods, 6th ed., pp. 172-175, Iowa State Univ. Press, Ames, IA.
29. Stirpe, F., Della Corte, E., Bonetti, E., Abbondanza, A., Abbati, A., and de Stefano, F. (1970). Fructose-induced hyperuricaemia. Lancet 2, 1310-1311.
30. Van den Berge, G. (1986). Fructose: Metabolism and short-term effects on carbohydrate and purine metabolic pathways. In Metabolic Effects of Dietary Carbohydrates (I. Macdonald and A. Vrana, Eds.), Progress in Biochemistry and Pharmacology, Vol. 21, pp. 1-32, Karger, Basel, Switzerland.
31. Vincent, M. F., Van den Berghe, G., and Hers, H.-G. (1989). Increase in phosphoribosyl pyrophosphate induced by ATP and Pi depletion in hepatocytes. FASEB J. 3, 1862-1867.
32. World Health Organization (1985). Diabetes Mellitus: Report of a WHO Study Group. Tech. Rep. Ser., No. 727. Geneva, World Health Org.
33. Yamamoto, T., Moriwaki, Y., Takahashi, S., Suda, M., and Higashino, K. (1995). Xylitol-induced increase in the concentration of oxypurines and its mechanism. Int. J. Clin. Pharm. Ther. 33, 360-365.